At the same time, in the SKP2-/_model, the nuclear p27 expression is higher than SKP2-/-counterparts, demonstrating that leukemogenesis attenuation is regulated by high p27 levels in both MPD and CML (33, 82). This evidence concerns the gene CDKN1B and myeloproliferative disorder.